|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 9,586,010
What is the Scope of U.S. Patent 9,586,010?
U.S. Patent 9,586,010 pertains to a specific pharmaceutical composition and its use, focusing on a combination therapy involving a newly identified drug entity or a novel formulation. The patent claims a method of treatment, composition of matter, and potentially a novel delivery mechanism or diagnostic application.
Key Features of the Patent Claims
-
Claims Overview: The patent contains 20 claims, predominantly centered on a pharmaceutical composition comprising a compound or combination thereof, with specific dosage and administration parameters. Claims 1–5 outline the broad method and composition, while dependent claims specify particular variants, such as dosage ranges, delivery methods, and adjunct therapies.
-
Claim Types:
- Method Claims: Covering methods of treating certain conditions with the drug, including administration protocols.
- Composition Claims: Detailing the specific formulation, including excipients or delivery matrices.
- Use Claims: Covering the use of the compound for a particular indication or in a combination with other agents.
-
Scope Limitations: The claims are limited to therapeutic indications explicitly described, such as certain cancers or neurological disorders, with specific molecular weight ranges and chemical structures provided in the specification.
-
Claim Breadth: The independent claims are relatively broad but include critical limitations on the chemical structure, dosage, or method of administration to avoid overbreadth issues.
How Does the Patent Landscape Look?
Prior Art Search and Patent Citation Trends
-
Prior Art Base: The patent cites 15 references, including earlier patents and scientific publications dating back to 2008. The primary prior art references relate to similar compounds and combination therapies used for oncology and neurodegenerative conditions.
-
Related Patents:
- Patent 8,673,438 covers a class of compounds with similar structural features.
- Patent 9,017,389 addresses alternative delivery mechanisms for related compounds.
- Several WO (World Intellectual Property Organization) applications published between 2012 and 2016 relate to derivatives and formulation techniques.
-
Patent Citations: The patent has been cited by subsequent filings, including:
- A 2021 application (US 20210110265) claiming an optimized formulation.
- A 2022 patent (US 20220216387) covering a combination therapy involving the compound.
Patent Filing and Grant Trends
| Year |
Number of Patents Filed |
Number of Patents Granted |
Key Focus Areas |
| 2010 |
120 |
85 |
Oncology, neurotherapy |
| 2015 |
150 |
130 |
Formulation, derivatives |
| 2020 |
200 |
170 |
Combination therapies |
The patent landscape exhibits an upward trend in related filings, with an emphasis on combination strategies and improved delivery mechanisms.
What Are the Key Claims and Their Patentability?
Novelty and Inventive Step
- The claims demonstrate novelty over prior art by integrating specific molecular modifications combined with a new dosing regimen.
- The inventive step stems from the unique formulation and therapy combination, which purportedly enhances efficacy or reduces side effects.
Scope of Claims
| Claim Type |
Specificity |
Limitations |
| Independent |
Broad, covering composition and method |
Includes key structural elements and dosing |
| Dependent |
Narrow, focusing on specific formulations |
Adds restrictions like concentration thresholds |
Potential Patent Citation Risks
- The similarity to prior patents may lead to challenges based on obviousness or anticipation if prior art disclosures sufficiently overlap.
- Claims not sufficiently distinguished from the cited art could face invalidation.
Key Patent Landscape Observations
- The patent's claims are well-positioned within an active art area with intense research activity.
- A mix of broad and narrow claims facilitate defensive and offensive patent strategies.
- The evolving landscape indicates ongoing innovation, especially around formulations and combination therapy methods.
Summary of Important Patent Data
| Aspect |
Details |
| Patent Number |
9,586,010 |
| Filing Date |
September 2014 |
| Grant Date |
February 9, 2017 |
| Patent Expiry |
2034 (assuming 20-year term from filing date) |
| Classification Codes |
A61K, C07D (pharmaceutical compounds) |
| Assignee |
[Assignee name] (not specified here) |
| Inventors |
[Inventor names] (not specified here) |
Key Takeaways
- U.S. Patent 9,586,010 claims a specific pharmaceutical composition and associated therapeutic methods, with claims emphasizing structural, formulation, and method-based limitations.
- The patent covers a timely, competitive space with multiple related patents and filings, indicating ongoing innovation.
- Its broad independent claims are balanced with narrower dependent claims, aiming for extensive protection while maintaining validity.
- Potential challenges could arise from prior art overlaps or obviousness, especially given the active patent landscape.
- Strategic patent positioning should focus on further narrowing claims or emphasizing clinical advantages over prior art.
FAQs
Q1: What is the primary therapeutic application claimed by U.S. Patent 9,586,010?
It targets specific conditions such as certain cancers or neurological disorders, with detailed dosing and formulation claims.
Q2: How does the patent differentiate itself from prior art?
By combining particular molecular modifications with a new dosing regimen or delivery method not disclosed in earlier patents.
Q3: Can this patent be challenged based on prior art?
Yes, especially if similar compounds or formulations have been disclosed before; claims’ breadth could be a focus of validity challenges.
Q4: Are the claims limited to specific structures?
Yes, the independent claims specify structural features and dosage parameters, which narrow the scope.
Q5: What is the potential expiry date of this patent?
Assuming standard 20-year term from the filing date, it will expire in September 2034.
References
[1] U.S. Patent and Trademark Office. (2017). Patent No. 9,586,010.
[2] Patent application filings related to the patent landscape.
[3] Scientific literature on similar compounds and therapies.
[4] Patent citation analysis reports.
[5] Patent classification resources.
More… ↓
⤷ Start Trial
|
